“…Compared to collecting or artificially cultivating the fruiting bodies of medicinal mushrooms, mycelium fermentation offers advantages such as a stable product spectrum, shorter cultivation time, and easy industrial scale-up, making it an ideal method for researching their bioactive substances . However, compared to their natural habitat, certain activating factors are often lacking under traditional axenic conditions, resulting in some gene clusters remaining silent. , Several strategies have been applied to awaken silent genes in fungi, including genetic engineering (such as overexpression or knockout of the genes for transcription factors and global regulators), , one strain many compounds (OSMAC, mainly by altering the culture conditions), , and coculture. , Among these methods, the coculture strategy can effectively activate silent metabolic pathways by simulating natural microbial relationships, such as competition and antagonism, thus avoiding the need to manipulate the complex genome of mushrooms and reducing the workload for screening . This strategy has been well applied to explore the metabolic potential of mushrooms, leading to the discovery of many novel antimicrobial compounds, including postredienes A–F, , pleurotusin A, copsin, and 23 R -hydroxy-(20 Z ,24 R )-ergosta-4,6,8(14),20(22)-tetraen-3-one .…”